About ProteoTech
ProteoTech is a company based in Kirkland (United States) founded in 1996 by Alan D. Snow. It operates as a B2B. ProteoTech has raised $10.02 million across 9 funding rounds from investors including HHS and The Michael J. Fox Foundation.
- Headquarter Kirkland, United States
- Founders Alan D. Snow
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.02 M (USD)
in 9 rounds
-
Latest Funding Round
$10.02 M (USD), Series B
Jun 24, 2011
-
Investors
HHS
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ProteoTech
ProteoTech has successfully raised a total of $10.02M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $10.02 million completed in June 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $10.0M
-
First Round
First Round
(01 Jul 2002)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2011 | Amount | Series B - ProteoTech | Valuation |
investors |
|
| Jun, 2011 | Amount | Grant - ProteoTech | Valuation |
investors |
|
| Jun, 2011 | Amount | Grant - ProteoTech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ProteoTech
ProteoTech has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and The Michael J. Fox Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Research for Parkinson's disease is funded by the foundation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ProteoTech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ProteoTech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proteotech Comparisons
Competitors of ProteoTech
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proteotech
Frequently Asked Questions about ProteoTech
When was ProteoTech founded?
ProteoTech was founded in 1996 and raised its 1st funding round 6 years after it was founded.
Where is ProteoTech located?
ProteoTech is headquartered in Kirkland, United States. It is registered at Kirkland, Washington, United States.
Is ProteoTech a funded company?
ProteoTech is a funded company, having raised a total of $10.02M across 9 funding rounds to date. The company's 1st funding round was a Grant of $770.68K, raised on Jul 01, 2002.
What does ProteoTech do?
ProteoTech, founded in 1996 in Kirkland, United States, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and protein disorder treatments. Develops innovative drugs for treating misfolded protein and amyloid diseases. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Who are ProteoTech's investors?
ProteoTech has 2 investors. Key investors include HHS, and The Michael J. Fox Foundation.